A talk with study author on a new combination of acimtamig and an allogeneic natural killer cell product that shows safety ...

Moderna vaulted to the forefront of biotech, becoming a major pillar of the region’s economy. But Robert F. Kennedy Jr.’s ...

The strong financials and positive sentiment may have contributed to GlaxoSmithKline Pharmaceutical's stock reaching a new 52 ...

It has been dubbed a “Trojan horse” treatment because it works by being taken into a cancer cell, before releasing a high ...

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

House Democrats sent letters to the potential buyers of the genetic testing company, asking how they plan to protect customer ...

Getting a cortisone shot for knee arthritis might provide quick pain relief, but new research reveals a troubling association ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...

Live Updates Live Coverage Has Ended Nvidia Drives Stock Market Higher 4:25 pm Strong performance from Dow Jones Industrial ...